CATALYST PHARMACEUTICALS, INC. — Director's Dealing 2012

Dec 14, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CATALYST PHARMACEUTICAL PARTNERS, INC. (CPRX)
CIK: 0001369568
Period of Report: 2012-12-12

Reporting Person: HUCKEL HUBERT E MD (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-12-12	Options to purchase common stock	$0.47	A	50000	Acquired	2017-12-12	Common Stock (50000)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Warrants to purchase common stock	$1.04	2017-05-30	Common Stock (125000)	125000	Indirect

Footnotes

F1: Derivative securities are held in a Grantor Retained Annuity Trust, the Trustee of which is Dr. Huckel.